Predicting Mouse Liver Microsomal Stability with “Pruned” Machine Learning Models and Public Data
- 28 September 2015
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 33 (2) , 433-449
Abstract
Mouse efficacy studies are a critical hurdle to advance translational research of potential therapeutic compounds for many diseases. Although mouse liver microsomal (MLM) stability studies are not a perfect surrogate for in vivo studies of metabolic clearance, they are the initial model system used to assess metabolic stability. Consequently, we explored the development of machine learning models that can enhance the probability of identifying compounds possessing MLM stability.Keywords
This publication has 91 references indexed in Scilit:
- Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian ModelsPLOS ONE, 2013
- Structure–Activity Relationship for FDA Approved Drugs As Inhibitors of the Human Sodium Taurocholate Cotransporting Polypeptide (NTCP)Molecular Pharmaceutics, 2013
- PubChem's BioAssay DatabaseNucleic Acids Research, 2011
- Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening DataJournal of Chemical Information and Modeling, 2011
- ChEMBL: a large-scale bioactivity database for drug discoveryNucleic Acids Research, 2011
- Predicting cytotoxicity from heterogeneous data sources with Bayesian learningJournal of Cheminformatics, 2010
- Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical librariesNature Biotechnology, 2009
- PubChem: a public information system for analyzing bioactivities of small moleculesNucleic Acids Research, 2009
- Monitoring Compound Integrity With Cytochrome P450 Assays and qHTSSLAS Discovery, 2009
- ErratumChemico-Biological Interactions, 1999